Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / XBIT - XBiotech launches new Influenza-COVID-19 antibody test


XBIT - XBiotech launches new Influenza-COVID-19 antibody test

XBiotech (XBIT) announces the launch of a new breakthrough candidate therapy called FLUVID for treating illness caused by combined infections with influenza and COVID-19.FLUVID therapy will combine XBiotech’s breakthrough influenza True Human antibodies together with its recently discovered COVID-19 antibodies into one treatment and will be used to provide immunity to infection or to treat infections once they have occurred.Shares are up 1% PM.

For further details see:

XBiotech launches new Influenza-COVID-19 antibody test
Stock Information

Company Name: XBiotech Inc.
Stock Symbol: XBIT
Market: NASDAQ
Website: xbiotech.com

Menu

XBIT XBIT Quote XBIT Short XBIT News XBIT Articles XBIT Message Board
Get XBIT Alerts

News, Short Squeeze, Breakout and More Instantly...